Evidence map›Paper›PMID 29779835›Full record

Trial reportJournal of diabetes and its complications2018

Concerns and hopes of patients with type 1 diabetes prior to islet cell transplantation: A content analysis.

Queena F Luu, Celine J Villareal, Cynthia Fritschi, Rebecca S Monson, Jose Oberholzer, Kirstie K Danielson

Open access · greenAbstract readClinical Trial, Phase IClinical Trial, Phase IIClinical Trial, Phase III
In one paragraph

Trial report in Journal of diabetes and its complications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Queena F LuuSchool of Public Health, University of Illinois at Chicago, 1603 W. Taylor St., Chicago, IL 60612, USA.
Celine J VillarealDepartment of Biobehavioral Health Science, College of Nursing, University of Illinois at Chicago, 845 S. Damen Ave., Chicago, IL 60612, USA.
Cynthia FritschiDepartment of Biobehavioral Health Science, College of Nursing, University of Illinois at Chicago, 845 S. Damen Ave., Chicago, IL 60612, USA. Electronic address: fritschi@uic.edu.
Rebecca S MonsonDepartment of Surgery, College of Medicine, University of Illinois at Chicago, 840 S. Wood St., Chicago, IL 60612, USA. Electronic address: rmonso2@uic.edu.
Jose OberholzerDepartment of Surgery, College of Medicine, University of Illinois at Chicago, 840 S. Wood St., Chicago, IL 60612, USA. Electronic address: jober@uic.edu.
Kirstie K DanielsonSchool of Public Health, University of Illinois at Chicago, 1603 W. Taylor St., Chicago, IL 60612, USA; Department of Surgery, College of Medicine, University of Illinois at Chicago, 840 S. Wood St., Chicago, IL 60612, USA. Electronic address: kdaniel@uic.edu.
University of Illinois Chicago · US

Funding

UIC Program for Interdisciplinary Careers in Women's Health ResearchK12HD055892 · NICHD · UNIVERSITY OF ILLINOIS AT CHICAGO · PI GELLER, STACIE E. · 2007 to 2016
$4.9M
NICHD NIH HHS K12 HD055892
6 · The paper itself

Abstract

aimsIslet cell transplantation can functionally cure type 1 diabetes complicated by hypoglycemia unawareness (HU), but requires immunosuppression. This study identified the lived experiences and risk/benefit considerations of patients pre-transplant.

methodsContent analysis identified themes from four open-ended questions pre-transplant in an islet transplant clinical trial. The sample included 23 (19 female) patients, with a mean age = 48.3 and diabetes duration = 29.3 years.

resultsLack of control due to diabetes and HU was the overarching theme pre-transplant. Four sub-themes were also identified: fear of hypoglycemia, diabetes-related complications, hopes/expectations after transplant, and transplant outcomes. Patients expressed fear of HU and long-term complications pre-transplant, and hoped islet transplant would improve diabetes management. Patients further emphasized anxiety over burdening others, and hopes of advancing research. In addition, other patients emphasized frustrations regarding the impact of HU on themselves, such as the inability to perform activities of daily living. Many patients were primarily worried about immunosuppressive side effects rather than islet transplant success.

conclusionsPatients viewed islet transplantation as a means to gain autonomy and control over their lives. They desired reduced anxiety associated with HU, despite concerns over immunosuppressive side-effects. These findings need confirmation, but may help to further improve patient education and patient-provider communication.

Indexed as

FearActivities of Daily LivingAdultDiabetes Mellitus, Type 1Drug-Related Side Effects and Adverse ReactionsFemaleHopeHumansHypoglycemiaImmunosuppressive AgentsIslets of Langerhans TransplantationMaleMiddle AgedPerceptionUnited StatesImmunosuppressive AgentsComplicationsHypoglycemia unawarenessImmunosuppressionIslet cell transplantationQuality of lifeType 1 diabetes

Identifiers

PMID29779835
PMCPMC6015784
OpenAlexW2803026705

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.